Private Equity
Potential LPs told North Africa-focused RMBV in 2020 that they would need to see more DPI from its prior vintages before committing to a new vehicle, PEI understands.
2 min read · 18 May 2023
ArchiMed and Warburg Pincus have agreed to sell the France-headquartered business to life science group Sartorius for approximately €2.4bn.
2 min read · 04 April 2023
The life sciences unit increased its original €175m hard-cap to allow for more investment into the portfolio companies it seeks to back.
2 min read · 29 March 2023
PE-backed healthcare businesses can help improve patient access and outcomes, but thorough due diligence, support and oversight are needed to ensure progress is made on ESG.
5 min read · 01 February 2023
Demographic shifts and the rising cost of care in Asia have boosted interest in the market, according to the SWF’s head of life sciences for direct investments in America.
5 min read · 24 January 2023
While private companies generally performed well last year, the listed firm's top economic forecaster Nicholas Brooks says conditions will be choppier.
3 min read · 19 January 2023
The darling of so-called ‘growth markets’ investing took just half a year to unravel in a saga that has yet to conclude.
3 min read · 29 November 2022
The pandemic made existing inequities in healthcare harder to ignore.
5 min read · 01 November 2022
A dislocated market and several niches could bode well for the sector, according to the EisnerAmper study.
2 min read · 25 October 2022
The mid-market firm raised around $10.2bn for its predecessor flagship in April last year.
2 min read · 28 September 2022
